MEGAN WELKER: Open Payments
NPI 1396196556 · MUNCIE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,483 in 148 payments from 32 companies in 2025. Trend: 2023 $1,229 · 2024 $1,808 · 2025 $2,483
Food & beverage: $2,483
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 38 | $528 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $248 |
| AstraZeneca Pharmaceuticals LP | 9 | $171 |
| Otsuka America Pharmaceutical, Inc. | 10 | $152 |
| Amgen Inc. | 11 | $135 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $123 |
| Biogen, Inc. | 5 | $112 |
| Axsome Therapeutics, Inc. | 5 | $101 |
| Indivior Inc. | 6 | $99 |
| Novo Nordisk Inc | 5 | $80 |
Products named: CAPLYTA, VRAYLAR, REXULTI, MAVYRET, OTEZLA, ZURZUVAE, AIRSUPRA, Auvelity.
Industry payments across IN — which companies pay providers there.
